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Stromal Fibroblasts Facilitate Cancer Cell Invasion by a Novel
Invadopodia-Independent Matrix Degradation Process
Abstract
Metastatic invasion of tumors into peripheral tissues is known to rely upon protease-mediated degradation of
the surrounding stroma. This remodeling process utilizes complex, actin-based, specializations of the plasma
membrane termed invadopodia that act both to sequester and release matrix metalloproteinases. Here we
report that cells of mesenchymal origin, including tumor-associated fibroblasts, degrade substantial amounts
of surrounding matrix by a mechanism independent of conventional invadopodia. These degradative sites lack
the punctate shape of conventional invadopodia to spread along the cell base and are reticular and/or fibrous
in character. In marked contrast to invadopodia, this degradation does not require the action of Src kinase,
Cdc42, or Dyn2. Rather, inhibition of Dyn2 causes a dramatic upregulation of stromal matrix degradation.
Further, expression and activity of matrix metalloproteinases are differentially regulated between tumor cells
and stromal fibroblasts. This matrix remodeling by fibroblasts increases the invasive capacity of tumor cells,
thereby illustrating how the tumor microenvironment can contribute to metastasis. These findings provide
evidence for a novel matrix remodeling process conducted by stromal fibroblasts that is substantially more
effective than conventional invadopodia, distinct in structural organization, and regulated by disparate
molecular mechanisms.
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Abstract
Metastatic invasion of tumors into peripheral tissues is known to rely upon protease-mediated 
degradation of the surrounding stroma. This remodeling process utilizes complex, actin-based, 
specializations of the plasma membrane termed invadopodia that act both to sequester and release 
matrix metalloproteinases. Here we report that cells of mesenchymal origin, including tumor-
associated fibroblasts, degrade substantial amounts of surrounding matrix by a mechanism 
independent of conventional invadopodia. These degradative sites lack the punctate shape of 
conventional invadopodia to spread along the cell base and are reticular and/or fibrous in character. 
In marked contrast to invadopodia, this degradation does not require the action of Src kinase, 
Cdc42, or Dyn2. Rather, inhibition of Dyn2 causes a dramatic upregulation of stromal matrix 
degradation. Further, expression and activity of matrix metalloproteinases are differentially 
regulated between tumor cells and stromal fibroblasts. This matrix remodeling by fibroblasts 
increases the invasive capacity of tumor cells, thereby illustrating how the tumor 
microenvironment can contribute to metastasis. These findings provide evidence for a novel matrix 
remodeling process conducted by stromal fibroblasts that is substantially more effective than 
conventional invadopodia, distinct in structural organization, and regulated by disparate molecular 
mechanisms.
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Introduction
Dissemination of neoplastic cells away from the primary tumor is a characteristic of 
metastatic invasion and is a primary obstacle to the treatment of cancer. Invasion requires 
complex, agonist-activated, and actin-based tumor cell migration machinery that works in 
tandem with the secretion of matrix-remodeling metalloproteinases (MMPs). This secretion 
of matrix-degrading proteases is believed to be largely coordinated by complex organelles 
termed “invadopodia,” protrusions of the plasma membrane built upon a core of actin 
filaments and scores of associated proteins (1). Invadopodia assembly and function are 
regulated by multiple factors, including the signaling activity of Src kinase, the actin 
remodeling properties of Cdc42, and the GTPase function of Dynamin 2 (2-5).The 
mechanisms by which these structures are regulated, formed, and facilitate protease 
secretion and activation are critical, as attenuating invadopodia function could reduce tumor 
dissemination.
Importantly, many tumor cells do not form invadopodia in culture, do not degrade the 
surrounding matrix, and do not themselves secrete proteases, yet are able to disseminate and 
invade robustly. Many solid tumors, in particular pancreatic tumors, consist predominantly 
of supportive stromal cells, generating a complex tumor microenvironment (6). This 
population of surrounding stellate cells and/or cancer associated fibroblasts (CAFs) may 
actually provide a significant stromal remodeling capacity to lead the way for invasive tumor 
cells (7). However, the mechanisms of matrix remodeling by stromal cells are not well 
characterized. Recent studies have implicated the actin regulatory protein palladin in 
promoting invadopodia formation by CAFs to contribute to tumor cell invasion (8, 9). In 
addition, stromal degradation can be dramatically upregulated in fibroblasts by expression of 
oncogenic Src, and this podosome-like degradation requires the GTPase Dynamin 2 (4, 10). 
However, mechanisms underlying fibroblast-based matrix degradation without ectopic 
expression of active Src are not well defined, and it is not clear if invadopodia are the 
primary drivers of matrix remodeling in stromal fibroblasts.
To this end, we have compared the matrix-degrading machinery of human cancer cell lines 
with that of multiple mesenchymal-derived supportive cells, including CAFs, pancreatic 
stellate cells, and non-cancer associated fibroblasts. While tumor cells largely utilize 
invadopodial-based degradation, the matrix degradation by stromal cells is markedly 
different. Stromal cell matrix degradation is tubular/reticular in organization, and is 
regulated by different molecular machinery than invadopodial degradation by the tumor 
cells. These findings suggest that neoplastic epithelial cells and supportive stromal cells 
exhibit differential mechanisms to mediate matrix remodeling. The non-invadopodial 
degradation by CAFs in the tumor microenvironment could possess a substantial capacity to 
amplify the invasive properties of the tumor cells.
Results
Differential requirements for the large GTPase Dynamin in matrix degradation
To compare the degradative patterns between epithelial tumor cells and stromally-derived 
mesenchymal fibroblasts, cells were plated on fluorescent gelatin-coated coverslips and 
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allowed to degrade the gelatin matrix (11). Cell models included human adenocarcinoma 
cell lines of pancreatic (BxPC3, DanG) and breast (MDA-MB-231) origin, and several 
mesenchymal cell lines including human foreskin fibroblasts, rat and mouse fibroblasts, and 
three different pancreatic stromal cell lines: CAFs isolated from human pancreatic ductal 
adenocarcinoma (PDAC) patient-derived xenografts, and normal pancreatic stellate cells 
(PSC-1 and PSC-2), which are thought to be a primary source of CAFs in pancreatic cancers 
(12).
Epithelial tumor cells degraded the fluorescent substrate in a punctate pattern, representing 
conventional invadopodia (Fig. 1a-c), and showed substantial colocalization with the 
invadopodial markers actin and cortactin (Fig. 1j). In contrast, stromal fibroblasts and 
stellate cells displayed a combination of peripheral filamentous, focal adhesion-like 
degradation patterns (13, 14) and a series of elaborate tubular-reticular networks (Fig.1d-g), 
which showed no colocalization with actin or cortactin (Fig. 1k). These data suggest the 
matrix degradation accomplished by the fibroblasts and PSCs is distinct from the 
invadopodial matrix degradation of the tumor cells. All cells displayed a wide range of 
degradative activity as well as variations in the amount of matrix degraded per cell, with 
90% of DanG and 35% of BxPC3 cells remodeling matrix, compared to just 25% of the 
human fibroblasts or <5% of the CAFs (Fig. 1h-i). Degradation by all cell types was 
completely inhibited by the MMP inhibitor BB-94, demonstrating that the degradation is 
protease-dependent (Supplementary Fig. S1). Interestingly, the area of degradation by the 
mesenchymal cells was notably higher than the BxPC3 or MDA-MB-231 tumor cells, which 
form bona fide invadopodia and are invasive (Fig. 1i). Therefore, this pattern of fibroblast-
based matrix degradation is at least as potent as the degradation by tumor cells, if not more 
so.
To test if these different degradative phenotypes represent distinct mechanistic processes by 
epithelial versus mesenchymal cells, we tested the requirement for the large GTPase 
dynamin in the capacity to form invadopodia. The ubiquitous form of dynamin (Dyn2) is 
essential for the formation and function of invadopodia, presumably by mediating structural 
interactions between the ventral cell membrane and the actin cytoskeleton (2, 10). Indeed, 
siRNA-mediated knockdown of Dyn2 significantly reduced invadopodia formation and 
matrix degradation in the adenocarcinoma cell lines (Fig. 2a-j, x-y). In surprising contrast, 
the reduction of Dyn2 in the stromal cells caused a massive increase in matrix degradation, 
with a significant enlargement of the tubular-reticular patterns that extend from the cell 
center to the periphery. Knockdown of Dyn2 in stromal cells induced a 4-8 fold increase in 
the percent of cells degrading the matrix (Fig. 2l-x), as well as a striking 2-6 fold increase in 
the area of matrix degraded per cell (Fig. 2y).
To pursue the unexpected finding that fibroblasts degrade more matrix under conditions of 
low Dyn2 expression, we utilized MEFs from dynamin knockout mice (15). These cells have 
an inducible knockout of Dyn1 and Dyn2 driven by 4-hydroxy-tamoxifen (4HT). Similar to 
the human and rat fibroblasts (Fig. 2), the parental MEFs (DKO) exhibit very low levels of 
matrix degradation. Strikingly, 4HT-induced knockout of Dyn2 resulted in a massive 
increase in matrix degradation, with a 6-fold increase in the percent of cells capable of 
degrading matrix and a 10-fold increase in degradation area per cell, and the induction of the 
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massive reticular degradation pattern (Fig. 3a-c, f-g). This increase is ablated in the 
knockout cells re-expressing wild type Dyn2, but not GTPase defective Dyn2K44A (Fig. 3d-
g). Similarly, overexpression of dominant negative Dyn2 K44A in rat fibroblasts induces the 
same dramatic matrix degradation, whereas expression of Dyn2 K44A in DanG tumor cells 
suppresses matrix degradation (Supplementary Fig. S2). Together, these data suggest that in 
fibroblasts, Dyn2 actually represses matrix degradation in a manner that requires its GTPase 
activity, a finding that is completely contrary to that observed in the epithelial-based tumor 
cells and contrary to the role of Dyn2 in the Src-induced, podosome-like degradation 
structures observed in mesenchymal cells (2, 10).
Fibroblast-derived ECM degradation is distinct from invadopodia-based degradation
The massive upregulation of matrix degradation by fibroblasts following depletion of Dyn2 
does not resemble conventional invadopodia, raising the exciting possibility that these 
degradative structures are not only morphologically different from those in epithelial cells, 
but also mechanistically distinct. Invadopodial-based matrix degradation in tumor cells 
colocalizes with puncta positive for actin and cortactin, components of invadopodia. 
However, the sites of matrix degradation by the fibroblasts and PSCs showed no 
colocalization with actin or cortactin (Fig. 1, Supplemental Fig. 3). We hypothesized that the 
reticular degradation pattern actually represented the accumulated degradation of multiple 
dynamic invadopodia over time. To test this, matrix degradation was imaged at very early 
timepoints. Stromal cells were depleted of Dyn2 to amplify the nontraditional matrix 
degradation, then plated on fluorescent gelatin-coated coverslips in the presence of the MMP 
inhibitor BB-94. The BB-94 was then washed out, and cells were fixed and stained after 0-8 
hours. Even within 1-2 hours, there was no colocalization between actin or cortactin with 
patterns of matrix degradation (Supplementary Fig. S3, Supplementary Movies 1-3), 
suggesting that the degradation is distinct from the canonical actin-based invadopodial 
machinery.
Src kinase activity induces invadopodia formation and maturation, and is required for 
invadopodial-based matrix degradation in tumor cells (4, 16). Consistent with this model, 
treatment of tumor cells with the Src inhibitor PP2 severely inhibited matrix degradation 
(Fig. 4a-d,i-j). We then tested the requirement for Src in fibroblast-based degradation. Using 
both DKO MEFs and rat fibroblasts, Dyn2 was depleted by tamoxifen treatment or siRNA to 
promote matrix degradation. The cells were then plated on the fluorescent gelatin substrate 
in the presence of PP2 or DMSO vehicle control. Surprisingly, PP2 treatment had no 
inhibitory effect on matrix degradation by fibroblasts, even at short timepoints (Fig. 4e-j, 
Supplementary Fig. S4), suggesting that Src activity is not required for this stromal-based 
matrix degradation. Similar results were observed in control fibroblasts without knockdown 
of Dyn2, which degrade matrix by a non-invadopodial mechanism but at a lower frequency 
(Supplementary Fig. S4). These findings further indicate that the degradation by the 
fibroblasts is mechanistically distinct from invadopodia.
The small GTPase Cdc42 is a well-characterized regulator of invadopodia formation (3, 17, 
18). Indeed, expression of dominant negative Cdc42 (T17N) inhibited matrix degradation in 
the DanG tumor cells (Fig. 4k-l,o-p). Therefore, we tested if the large-scale matrix 
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degradation induced in fibroblasts required Cdc42 activity. DKO MEFs were treated with 
4HT to induce dynamin knockout, were transfected with dominant negative Cdc42 (T17N), 
and were plated on the fluorescent gelatin substrate. Strikingly, dominant negative Cdc42 
had no effect on matrix degradation in the dynamin-depleted fibroblasts (Fig. 4m-p), while it 
dramatically inhibited matrix degradation in epithelial tumor cells. These data indicate that 
the fibroblast-derived matrix degradation is independent of Cdc42. Thus, taken together, 
these findings demonstrate that fibroblasts are able to degrade the extracellular matrix by a 
novel mechanism distinct from invadopodia. This robust, large-scale degradation is 
independent of the invadopodial master regulators Src and Cdc42, does not have the typical 
invadopodial architecture and degradation pattern, and has an opposite requirement for Dyn2 
compared to traditional invadopodia, thereby defining a unique mechanism of matrix 
degradation.
The trafficking of metalloproteinases differs in tumor cells versus stromal fibroblasts
Thus far, we have demonstrated an intriguing difference in the regulation of matrix 
degradation in fibroblasts versus epithelial-derived tumor cells. Depletion of Dyn2 in 
carcinoma cells inhibits invadopodia-based matrix degradation, whereas depletion of Dyn2 
in fibroblasts results in a dramatic upregulation of invadopodia-independent matrix 
degradation. In an attempt to identify the differences underlying the distinct mechanisms of 
matrix degradation between the two cell types, we assayed for changes in MMP activity. 
Dyn2 was depleted using siRNA or 4HT-induced knockout in both fibroblasts (HF, RF, PSC, 
DKO MEFs) and epithelial-derived tumor cells (DanG, BxPC3, MDA-MB-231), and culture 
medium supernatants were analyzed by gelatin zymography. Notably, knockdown of Dyn2 
in mesenchymal cells resulted in a significant upregulation of MMP-2 activity, while total 
levels of MMP-2 were not significantly altered (Fig. 5 a-b). In contrast, the epithelial-
derived tumor cells had comparatively lower levels of active and total MMP-2, as 
determined by both zymography and immunoblotting, and no increase in MMP-2 activity 
was observed in the tumor cells. These data suggest that matrix degradation in epithelial 
tumors and mesenchymal fibroblasts are accomplished differently, and that fibroblast-
mediated degradation may be regulated through MMP-2 activity, which in turn is modulated 
by Dyn2.
As total levels of MMP-2 protein were not significantly altered following Dyn2 knockdown, 
the data suggest that Dyn2 regulates activation of MMP-2. Pro-MMP-2 is cleaved and 
activated extracellularly by membrane-tethered MT1-MMP (membrane type 1-matrix 
metalloproteinase), a protease critical to invadopodia function and matrix degradation by 
tumor cells (19, 20). MT1-MMP surface retention is regulated by Dyn2 function in 
endocytosis (21). Therefore, we hypothesized that MT1-MMP was differentially regulated 
by Dyn2 in the fibroblasts and epithelial-derived cell types, thereby selectively activating 
MMP-2 and leading to the differential regulation of matrix degradation. To test this, total 
MT1-MMP levels were initially assessed by immunoblotting. In mesenchymal cells, 
knockdown of Dyn2 led to a modest 30-50% increase in total MT1-MMP levels. In contrast, 
in epithelial tumor cells, knockdown of Dyn2 led to a modest reduction (30-50%) in total 
MT1-MMP (Fig. 6a-b). As reduced levels of Dyn2 could restrict the endocytic 
internalization of the MT1 protease from invadopodia at the cell surface, leading to 
Cao et al. Page 5
Oncogene. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
increased matrix degradation, we next tested if the changes in total cellular levels of MT1 
translated to altered protease levels at the plasma membrane. Immunofluorescence was used 
to probe for MT1-MMP on non-permeabilized cells, thereby detecting only MT1-MMP on 
the cell surface. In mesenchymal cells, there was a striking (2-3.5 fold) increase in surface 
MT1-MMP following depletion of Dyn2 (Fig. 6c-g). In contrast, in the epithelial-derived 
tumor cells, knockdown of Dyn2 caused no increase, or induced a modest reduction of MT1-
MMP on the cell surface. MT1-MMP is a major regulator of matrix remodeling, as MT1-
MMP colocalized with sites of matrix degradation by both tumor cells and fibroblasts (Fig. 
6h-i). However, these data suggest that MT1-MMP expression and trafficking are 
differentially regulated by Dyn2 in different cell types, with Dyn2 positively regulating or 
not affecting MT1-MMP surface expression in epithelial tumor cells, which form 
invadopodia, and Dyn2 negatively regulating MT1-MMP surface expression in 
mesenchymal cells, which degrade the ECM by an invadopodia-independent mechanism.
Of note, the distinct types of matrix degradation accomplished by tumor cells versus stromal 
fibroblasts were not attributed to an endocytic block alone, as inhibiting endocytosis by 
siRNA-mediated knockdown of clathrin exacerbated both the invadopodia-based matrix 
degradation of tumor cells, and the reticular, non-invadopodial degradation of fibroblasts, 
and also induced a distinct, fibrous pattern of degradation by the PSC-2 cells (Fig. 6j-q). 
Therefore, while clathrin-mediated endocytosis contributes to matrix degradation in different 
cell types, presumably due to internalization and clearance of the degradative machinery, it 
is not the sole factor that distinguishes between the alternate degradative pathways.
The findings in Fig. 5 suggested that the upregulation of degradation by the stromal cells 
was mediated by an increase in MMP-2 activity. While depletion of Dyn2 in fibroblasts led 
to a dramatic increase in matrix degradation, as described above, this was completely 
prevented by knockdown of MMP-2 (Fig. 7a-h), suggesting that MMP-2 is indeed required 
for stromal matrix degradation. Similarly, siRNA-mediated knockdown of MT1-MMP 
resulted in a loss of MMP-2 activity (Fig. 7b), and also blocked matrix degradation in the 
Dyn2 knockdown cells, demonstrating that both proteases are required for this large-scale, 
invadopodia-independent matrix degradation (Fig. 7a-h). In contrast, whereas depletion of 
MT1-MMP in DanG tumor cells completely blocked matrix degradation, knockdown of 
MMP-2 had less of an effect (Fig. 7i-p). Similarly, treatment of fibroblasts with the MMP-2/
MMP-9 inhibitor SB-3CT completely blocked the matrix degradation amplified by loss of 
Dyn2, but had less of an effect on DanG tumor cells (Supplementary Fig. S5). These data 
support a model by which MT1-MMP is a major activator of matrix degradation by both 
stromal cells and tumor cells, but that stromal cell degradation is mediated through MMP-2, 
whereas tumor cell degradation is less dependent upon MMP-2. Further, MMP-2 activation 
appears to distinguish the tubular/reticular degradation of mesenchymal cells from the 
punctate, MMP-2-independent, invadopodial degradations made by epithelial tumor cells 
(Fig. 7n).
Fibroblast-based matrix degradation promotes invasion by pancreatic tumor cells
Our findings indicate that fibroblasts can degrade the extracellular matrix by a novel 
mechanism that is distinct from tumor-associated invadopodia. In the context of the tumor 
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microenvironment, it is hypothesized that cross-talk between the tumor cells and stromal 
cells primes tumor cells for metastasis, with the fibroblasts creating a permissive 
environment that promotes invasion. One model is that the stromal cells contribute to tumor 
cell invasion by degrading and remodeling the extracellular matrix to allow tumor cell 
escape. Therefore, we tested if the fibroblast-based matrix degradation could support 
invasion by tumor cells in vitro using a co-culture model system.
PANC1 pancreatic tumor cells, which do not degrade a gelatin matrix, show minimal 
invasion through a gelatin-coated transwell membrane. We tested if providing stromal cells 
to degrade the matrix could promote PANC1 cell invasion. To this end, PANC1 cells were 
co-cultured with the stromal fibroblasts described above, and the resulting transwell invasion 
by PANC1 cells was quantified. Rat fibroblasts or CAFs were depleted of Dyn2 by siRNA, 
and then were co-cultured in a transwell invasion assay with PANC1 cells (Fig. 8e). When 
plated together, PANC1 cells were able to invade across a gelatin-coated transwell filter. 
Strikingly, depletion of Dyn2 in the fibroblasts, which induces matrix degradation, resulted 
in a marked upregulation of PANC1 invasion. Similar results were observed using DKO 
fibroblasts that were incubated with or without 4HT to induce Dyn2 knockout (Fig. 8a-d,f). 
The transwell invasion was inhibited by the MMP inhibitor BB-94, demonstrating that the 
invasion is dependent upon MMP activity and matrix degradation, and suggesting that the 
matrix-degrading capacity of the stromal fibroblasts promotes the transwell invasion of the 
tumor cells.
In line with these observations, co-culture with tumor cells capable of degrading the matrix 
should also promote the invasion of the PANC1 tumor cells. Indeed, co-culture with DanG 
cells, which exhibit potent matrix degradation, dramatically increased the transwell invasion 
of the PANC1 cells. In contrast to the stromal fibroblasts, siRNA-mediated depletion of 
Dyn2 in the DanG cells completely suppressed the induced invasion, consistent with the 
inhibitory effect on matrix degradation (Fig. 8g, Fig. 2). These data demonstrate that the 
invadopodia-independent matrix degradation inducible in fibroblasts is capable of promoting 
invasion of co-cultured tumor cells, and defines a novel mechanism by which fibroblast-
tumor cell interactions in the tumor microenvironment could contribute to metastasis.
Discussion
Complex interactions between tumor cells and neighboring stromal cells regulate tumor 
progression and metastasis. In a mutualistic interaction, tumor cells activate adjacent 
fibroblasts, which then are primed both to remodel the extracellular matrix and secrete trans-
acting factors to regulate the tumor cells. It has been proposed that CAFs can also secrete 
matrix-degrading proteases that could allow for the escape of tumor cells from the primary 
tumor. While tumor cells often degrade the matrix through the formation of specialized 
protrusions called invadopodia, in contrast, here we report a distinct mechanism of matrix 
degradation by fibroblasts regulated by the activity of the large GTPase Dyn2. This 
degradation is independent of invadopodia, as it exhibits a distinct pattern of degradation, 
does not require the activity of the kinase Src or the GTPase Cdc42, and is actually 
repressed, rather than supported, by the action of Dyn2. This novel form of matrix 
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degradation can support invasion by tumor cells, indicating a new mechanism by which 
stromal fibroblasts can promote tumor cell invasion.
CAFs have been extensively described as tumor-promoting, although their ablation also 
contributes to enhanced tumor growth and progression (22, 23), indicating a complex 
relationship between CAFs and tumor cells in vivo. CAFs promote tumor progression 
through secretion of cytokines and growth factors that stimulate tumor cell growth and 
migration, through maintenance of cancer stem cell properties, and by contributing to tumor 
cell metabolism (12, 24-29). In addition, CAFs have been implicated as direct regulators of 
tumor cell migration through mechanical regulation or serving as “leader” cells (7, 30). In 
this manuscript, we focus on the matrix-remodeling contribution of fibroblasts from both 
normal and neoplastic tissue. This matrix remodeling is highly relevant to multiple 
pathological settings such as fibrosis and wound healing, and is also able to promote tumor 
cell invasion in vitro (Fig. 8), demonstrating a significance during metastasis.
What is the structural basis of this invadopodia-independent matrix degradation in stromal 
fibroblasts? The pattern of degradation is reticular, suggesting a “tethering” of the proteases 
by cytoskeletal elements, yet we observed no obvious colocalization with a variety of 
cytoskeletal and organelle markers such as actin, cortactin, tubulin, the Golgi protein 
GM130, clathrin, or focal adhesion markers (Fig. 1, Supplementary Fig. S2, and data not 
shown). Our data suggest that this degradation is due to increased surface expression of 
MT1-MMP and increased activity of MMP-2, a secreted protease. However, the degradation 
is clearly focal, suggesting that the degradation is still associated with the membrane or a 
membrane-associated structure, and not just a result of excess soluble protease. Of note is 
the copious amount of matrix degradation induced in the fibroblasts in a short timeframe, 
compared to modest, punctate degradation originating from invadopodia (Figs. 1,2). While 
localized invadopodial degradation may be useful at the tip of an invading tumor cell to 
sense or degrade its local environment, the findings presented here raise the intriguing 
possibility that this novel type of fibroblast-derived matrix degradation may be important for 
large-scale matrix remodeling or invasion.
What molecular mechanisms account for the differences in matrix degradation between 
stromal and epithelial-derived tumor cells? Our data indicate that Dyn2 differentially 
regulates MMP-2 activity (Fig. 5), likely through surface expression of MT1-MMP. In 
fibroblasts, depletion of Dyn2 results in increased MT1-MMP at the cell surface (Fig. 6), 
consistent with the model that Dyn2 may be required for MT1-MMP endocytosis and 
internalization (21). Increased MT1-MMP at the surface would be available to activate 
extracellular MMP-2, which is increased in fibroblasts. However, inhibition of endocytosis 
by clathrin knockdown does not always phenocopy loss of Dyn2, particularly in epithelial 
tumor cells (Fig. 6). It is surprising that Dyn2 has these differential effects on MT1-MMP 
surface expression between the two cell types, and it will be important to determine how 
either MT1-MMP and/or Dyn2 are differentially regulated between mesenchymal and 
epithelial-derived cells.
How would this large-scale, invadopodia-independent degradation be induced in the context 
of human tumors? Fibroblast-derived matrix degradation was upregulated in this study by 
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depletion of Dyn2, which was used as a tool to manipulate signaling pathways and reveal a 
unique mechanism of degradation. While it is possible that Dyn2 expression is lost in CAFs, 
it is more likely that Dyn2-regulated signaling pathways could be altered in CAFs, such as 
endocytic or endosomal trafficking, or Dyn2-regulated cytoskeletal networks. Importantly, 
the differential regulation of matrix remodeling between tumor and stromal cells will 
increase the complexity of designing therapies to block tumor cell invasion. Inhibitors 
targeting classical invadopodial-based matrix degradation in tumor cells would not inhibit 
the large-scale matrix degradation inducible in fibroblasts, and could actually potentiate it, 
as in the case of Dyn2 depletion. These findings underscore the importance of defining the 
contributions of diverse cell types in the tumor microenvironment, and in understanding the 
basic cell biology underlying the mechanisms of invasion and migration in distinct cell 
types.
MATERIALS AND METHODS
Cell culture and transfection
BxPC-3 cells (ATCC CRL-1687), were maintained in RPMI-1640 medium with 10% fetal 
bovine serum (FBS) (Sigma, St. Louis, MN), 100 U/ml penicillin (P), and 100 mg/ml 
streptomycin (S) (Life Technologies, Carlsbad, CA). Human foreskin fibroblasts (HF, ATCC 
CRL-110), were maintained in MEM medium with 10% FBS and P/S. The following cell 
lines were maintained in DMEM medium with 10% FBS and P/S: PANC-1 (ATCC 
CRL-1469); DanG (provided by Dr. Martin Fernandez-Zapico, Mayo Clinic, Rochester, 
MN); MDA-MB-231 (ATCC HTB-26); rat fibroblasts (RF, ATCC CRL-1213); CAF cells 
(human cancer-associated fibroblasts, provided by Dr. Mark Truty, Mayo Clinic, Rochester, 
MN); human pancreatic stellate cells (PSC-1 provided by Dr. Debabrata Mukhopadhyay, 
Mayo Clinic, Rochester, MN; PSC-2 from ScienCell, Carlsbad, CA); and DKO (Dynamin 
conditional knockout fibroblasts, provided by Dr. Pietro De Camilli, Yale University, New 
Haven, CT, (15)). Dynamin 1/2 knockout was induced by treatment with 2 μM 4-hydroxy-
tamoxifen for 4-5 days. All cells were maintained in 5% CO2 at 37°C. Inhibitors used were: 
MMP inhibitor BB-94 (2 μM, Tocris Bioscience, Bristol, UK), Src inhibitor PP2 
(Calbiotech, Spring Valley, CA), or the MMP-2/MMP- 9 inhibitor SB-3CT (14 nM, Sigma, 
St. Louis, MO).
Cells were transfected with plasmid DNA using Lipofectamine 2000 and with siRNA using 
Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's instructions.
GFP-tagged and untagged Dyn2(aa) WT and K44A were described previously (31-34). 
Flag-tagged human Cdc42 T17N was provided by Dan Billadeau (Mayo Clinic, Rochester, 
MN). Myc-tagged human Cdc42 T17N was from Addgene (Addgene plasmid 12973, 
provided by Gary Bokoch).
Non-targeting siRNA and all targeting siRNAs were from Dharmacon (GE Healthcare): 
Human MMP-14 (MT1-MMP, #D-004145-02-0010); Dyn2 (Rat: D-080140-02, Human: 
D-004007-02) (35); MMP-2 (5’-GGAGAGCUGCAACCUGUUU-3’) (36); Clathrin 
(#D-004001-02-0050).
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Immunoblotting
For western blotting, cells were lysed in NP-40 lysis buffer (20 mM Tris-Cl, pH 8.0, 137 
mM NaCl, 10% glycerol, 1% NP-40, 2 mM EDTA, Complete protease inhibitors (Roche)), 
and immunoblotted as described (32). Primary antibodies were: MT1-MMP (Epitomics, 
Burlingame, CA); MMP-2 (EP1183Y, Abcam, Cambridge, MA) and (H-76:sc-10736, Santa 
Cruz Biotechnology, Dallas, TX), cortactin (4F11, EMD Millipore, Billerica, MA), Dyn2 
(37), and actin (Sigma). Horseradish peroxidase (HRP)-conjugated secondary antibodies 
were from Bio-source International (Camarillo, CA). Membranes were developed with 
enhanced chemiluminescence (Pierce) and were exposed to autoradiographic film (Eastman 
Kodak, Rochester, NY) to detect HRP.
Gelatin Zymography
Cells were cultured in the absence of serum for 24 hours. The culture medium was then 
collected and centrifuged for 2 min at 6000 rpm, then combined with zymogram sample 
buffer (BioRad, Hercules, CA), and incubated at room temperature for 10 minutes. Samples 
were resolved on a 7.5% SDS-PAGE gel containing 1 mg/ml gelatin. The gel was then 
incubated in 2.5% Triton X-100 at room temperature for 40 minutes with shaking, and 
rinsed with incubation buffer (50 mM Tris-B pH8.0; 150 mM NaCl; 10 mM CaCl; 0.05% 
NaN3), then soaked in incubation buffer at 37°C for 20~24 hours in a shaking waterbath. 
The gel was then rinsed three times with dH2O, stained with Coomassie blue for 40 minutes 
at room temperature, and destained at room temperature for 2 hours.
Fluorescent Gelatin Degradation Assay
Gelatin-coated coverslips were prepared as described using Oregon green 488-labeled 
gelatin (Life Technologies) at a 1:8 ratio with unlabeled gelatin (11). Cells were plated on 
gelatin-coated coverslips and incubated for 8 hours. Alternatively, cells were incubated 
overnight in the presence of 2 μM BB-94 (Tocris). The following day, BB-94 was washed 
out and the cells were incubated for 8 hours before fixation and staining.
Cell Invasion Assay
Polycarbonate membranes (NeuroProbe, Inc., Gaithersburg, MD) containing 8 μm pores 
were coated with 0.3% gelatin and assembled into Blind Well Chambers (NeuroProbe, Inc.). 
PANC-1 were stably transduced with a lentivirus to express mDsRed (35), and were mixed 
with the indicated cell types in low-serum media (0.2% FBS). 1×105 PANC1 and 2×104 
stromal cells were plated into the top chamber. The lower chamber contained DMEM with 
10% FBS. After 8 hours, the cells were removed from the top of the filter, and the filters 
were fixed with formaldehyde, stained with DAPI and FITC-Phalloidin (Sigma), and imaged 
by fluorescence microscopy. Cells were scored as invaded if the nucleus had crossed the 
filter. The number of PANC1 cells on the bottom of the filter was counted in 4-5 10× fields 
per filter.
Immunofluorescence and Microscopy
Cells were prepared for immunofluorescence as described previously (32). Cells were 
incubated in primary antibodies for 2 h at 37°C (myc or FLAG polyclonal, Cell Signaling 
Cao et al. Page 10
Oncogene. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Technologies; Dyn2 (37); MT1-MMP, Epitomics), washed with D-PBS, and incubated in 
labeled secondary antibody (Life Technologies) for 1 h at 37°C. Actin was stained using 
TRITC-Phalloidin (Sigma). The coverslips were mounted on glass slides using ProLong 
mounting medium (Molecular Probes, Life Technologies), and cells were imaged with an 
AxioObserver D.1 epifluorescence microscope (Carl Zeiss, Thornwood, NY) equipped with 
a 100-W mercury lamp using a 63×, 1.4 N.A. objective lens. Matrix degradation was 
visualized as a loss of Oregon green fluorescence on the labeled gelatin substrate. Contrast 
and intensity for each image were manipulated uniformly using Adobe Photoshop software. 
Images were analyzed with IVision software (BioVision, Mountain View, CA) (32).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Epithelial tumor cells and stromal cells exhibit distinct patterns of matrix degradation
Multiple different epithelial-derived tumor cells and mesenchymal cell types were plated on 
a fluorescent gelatin substrate and cultured for 8 hours prior to fixation. (a-c) The pancreatic 
tumor cells BxPC3 and DanG, and breast cancer cell line MDA-MB-231, show largely 
punctate, invadopodial-like degradation patterns. (d-g) Fibroblasts and stellate cells exhibit a 
unique pattern of centrally positioned, reticular matrix degradation. Boxed regions are 
magnified in insets. (h) Graph depicting the percentage of each cell type that degrades 
matrix after 8 hours. Graphed results represent the mean +/− S.D. of >100 cells in each of 
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three independent experiments. (i) Of the cells that degraded the matrix, the area of 
degradation was quantified and normalized to the total cell area. Graphed results represent 
the mean +/− S.D. of 10 cells in each of three independent experiments. (j) Matrix 
degradation by DanG cells colocalizes with actin and cortactin, indicating the presence of 
functional invadopodia. (k) In contrast, matrix degradation by PSCs shows no colocalization 
with actin or cortactin. RF: rat fibroblasts, HF: human fibroblasts, PSC: pancreatic stellate 
cells, CAF: cancer associated fibroblasts. Scale bar, 10 μm.
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Figure 2. Reduction of Dynamin 2 induces a differential response in matrix degradation between 
tumor and mesenchymal cells
(a-j) Dyn2 was depleted by siRNA in DanG, BxPC3, or MDA-MB-231 tumor cells, and 
cells were then plated on a fluorescent gelatin substrate. (a) Knockdown was confirmed by 
immunoblotting. The percent of the Dyn2 knockdown is indicated under the blot. (b-j) 
Tumor cells that spontaneously degrade matrix via invadopodia are markedly inhibited in 
their degradative capacity by Dyn2 knockdown. (k-w) Dyn2 was depleted by siRNA in RF, 
HF, and PSC-2, and cells were then plated on a fluorescent gelatin matrix. In contrast to the 
tumor cells, mesenchymal fibroblastic cells that normally exhibit modest amounts of 
degradation show increased matrix remodeling by 4-5-fold upon reduction of Dyn2. Most 
degradation is in a reticular-like pattern at the center of the cell. (x) Quantification of the 
percentage of cells degrading matrix after 8 hours. Results represent the mean +/− S.D. of 
>100 cells in each of three independent experiments. (y) Of the cells degrading matrix, the 
area of degradation was quantified and is normalized to the total cell area. Graphed results 
represent the mean +/− S.D. of 10 cells in each of three independent experiments. Note the 
reciprocal response in the tumor vs the stromal cells following Dyn2 KD. Scale bar, 10 μm. 
*p<0.05, **p<0.01.
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Figure 3. The substantial increase in degradation by Dynamin KO MEFs is reversed by Dynamin 
re-expression, and is dependent on its GTPase activity
A fibroblast cell line derived from an inducible Dyn1/2 genetic knockout (KO) model was 
analyzed for matrix degradation in the presence and absence of 4-hydroxy-tamoxifen (4HT) 
to induce dynamin knockout (DKO). (a, b) Parental [Tamoxifen (−)] or DKO [Tamoxifen 
(+)] MEFs plated on a fluorescent gelatin substrate were stained for Dyn2. Parental MEFs 
show substantial amounts of endogenous Dyn2, but exhibit almost no matrix degradation 
(a’). In contrast, DKO MEFs show a dramatic increase in matrix degradation with a 
characteristic reticular network pattern at the cell center (b’). (c) Western blot analysis of 
cells +/− tamoxifen treatment confirming Dyn2 knockout. The percent reduction in Dyn2 is 
shown. (d-e) Re-expression of Dyn2 in DKO MEFs results in a reversal of the degradation 
phenotype. Fluorescence images show re-expression of WT Dyn2 (d) or GTPase-deficient 
K44A Dyn2 (e) with corresponding degradation patterns on fluorescent gelatin (d’-e’). Note 
that the surrounding cells in which dynamin is not expressed degrade large amounts of 
matrix in comparison to the WT rescued cells (*) that degrade no matrix at all (d’). (f) 
Quantitation of the percentage of MEFs degrading matrix +/− DKO from three independent 
experiments, presented as the mean +/− S.D. Note that the Dyn2 K44A mutant-expressing 
cells continue to degrade matrix, indicating that the GTPase activity of Dyn2 is required to 
suppress degradation. Quantitative data represent the mean +/− S.D. of >100 cells in each of 
three independent experiments. (g) Of the cells degrading matrix, the area of degradation 
was quantified and normalized to the total cell area. Data represent the mean +/− S.D. of 10 
cells per condition in each of three independent experiments. Bar, 10 μm. ** p<0.01.
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Figure 4. Matrix degradation by epithelial-derived tumor cells versus fibroblasts exhibits distinct 
requirements for Src kinase and Cdc42
(a-h) The indicated cell lines were plated on a fluorescent gelatin substrate in the presence of 
the MMP inhibitor BB-94. Following BB-94 washout, the cells were incubated +/− the Src 
inhibitor PP2 (25μM) for 8h. (a-d) Note that matrix degradation by the DanG and BxPC3 
tumor cells is significantly reduced by Src inhibition. (e-h) Rat fibroblasts depleted of Dyn2 
(RF Dyn2 KD) or Dynamin knockout MEFs (DKO) were plated on fluorescent gelatin as 
described above. In contrast to the tumor cells, both mesenchymal cell types continue to 
degrade large amounts of matrix, even under these high concentrations of PP2. (i) 
Quantification of the percentage of cells degrading matrix upon Src inhibition (n>100 cells 
per condition) or (j) the area of degradation per cell, normalized to total cell area, in matrix-
degrading cells (n=10 cells per condition). (k-n) DanG tumor cells (k, l) or DKO MEFs (m, 
n) were transfected with dominant negative Cdc42 T174N and plated on fluorescent gelatin 
for 8h. Note that expression of Cdc42 T17N inhibits invadopodia-based matrix degradation 
by DanG cells, but not degradation by DKO MEFs. (o) Quantification of the percentage of 
cells degrading the matrix (n>50 cells per condition) and (p) the area of degradation per cell, 
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normalized to total cell area, in matrix-degrading cells (n≥10 cells per condition). All 
graphed data are represented as the mean +/− S.D. from three independent 
experiments.*p<0.05, **p<0.01.
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Figure 5. Differential expression and activation of the MMP-2 protease in stromal cells versus 
epithelial-derived tumor cells
(a) Western blot analysis of total MMP-2 protein levels in different mesenchymal and tumor 
cell lines following Dyn2 knockdown or knockout (T= tamoxifen-induced knockout). The 
percent knockdown of Dyn2 is included below the immunoblots. (b) Culture medium 
supernatant from the indicated cell lines was analyzed by zymography. Note the increase in 
gelatin degradation at the size of activated MMP-2 in fibroblasts and PSCs following 
depletion of Dyn2, while epithelial tumor cells show little or no MMP-2-based gelatin 
degradation. In both a and b, vertical white lines indicate regions where nonadjacent lanes 
were spliced together.
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Figure 6. Reduction of Dyn2 causes an accumulation of MT1-MMP on the plasma membrane in 
stromal cells
(a) Western blot analysis of total MT1-MMP protein levels in mesenchymal and tumor cell 
lines following depletion of Dyn2 (T= tamoxifen induced knockout). White space indicates 
where blots were spliced. (b) Quantitation of three experiments shows an accumulation of 
MT1-MMP protein upon Dyn2 knockdown in mesenchymal cells, but not tumor cells. 
Results indicate the mean +/− S.D. of MT1-MMP levels, normalized to the control for each 
cell type. (c-f’) Immunofluorescence staining of cell surface MT1-MMP with and without 
knockdown of Dyn2. Following Dyn2 depletion, fibroblasts showed a significant increase in 
surface MT1-MMP, while the tumor cells showed a modest reduction. (g) Quantification of 
cell surface MT1-MMP fluorescence intensity of each cell type +/− Dyn2 knockdown. 
Values were normalized to background fluorescence, and normalized to the control for each 
condition. Results represent the average+/− S.D. of >100 cells in each of three independent 
experiments. (h-i) Colocalization of MT1-MMP with areas of matrix degradation in both 
MDA-MB-231 tumor cells and rat fibroblasts that have been depleted of Dyn2. (j-q) Matrix 
degradation patterns of tumor or stromal cells that were depleted of clathrin by siRNA and 
plated on a fluorescent gelatin matrix. KD of clathrin increases degradation at tumor cell 
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invadopodia and at non-invadopodial sites in stromal cells. (r) The percent of cells degrading 
the matrix was scored (n>50 cells per condition, mean +/− S.D. from 2 independent 
experiments). (s) Of the cells degrading matrix, the area of matrix degradation was 
determined and normalized to the total cell area (n=10 cells per condition, mean +/− S.D. 
from 2 independent experiments). Bar, 10 μm. *p<0.05, **p<0.01.
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Figure 7. Non-invadopodial degradation requires MT1-MMP-stimulated MMP-2 activity
MT1-MMP (MT1), MMP-2, and Dyn2 were depleted by siRNA in PSCs or DanG tumor 
cells. The knockdowns were confirmed by western blot (a, i), and MMP-2 activity was 
assessed by zymography (b, j). (c-f) PSCs depleted of the indicated proteins were plated on 
fluorescent gelatin and matrix degradation was assessed after 8h. Knockdown of either 
MT1-MMP or MMP-2 inhibited the gelatin degradation in PSCs that was induced by loss of 
Dyn2. (k-n) In contrast, in DanG cells, invadopodial-based matrix degradation is blocked by 
siRNA-mediated depletion of either Dyn 2 or MT1-MMP, but is less affected by knockdown 
of MMP-2. (g, o) Quantitation of the percent of cells degrading the matrix (n>100 cells per 
condition), or (h, p) the area of degradation per cell, normalized to cell area, in matrix-
degrading cells (n=10 cells per condition). Graphed data are shown as the mean +/− S.D. of 
three independent experiments. Bar=10 μm. **p<0.01.
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Figure 8. Matrix degrading fibroblasts accentuate the transwell invasion of tumor cells
PANC1 tumor cells, which do not degrade a gelatin matrix or invade across a transwell filter, 
were transduced to stably express mDsRed. The labeled PANC1 cells were cultured alone or 
co-cultured with stromal cells in a transwell invasion assay. (a-d) Representative images 
showing PDAC cells that have invaded across a gelatin-coated transwell membrane. PANC1 
tumor cells were cultured individually (a), or co-cultured with parental DKO MEFs (b) or 
DKO MEFs treated with tamoxifen (4HT) to induce loss of Dyn2 (c). (d) Invasion was 
significantly reduced by the MMP inhibitor BB-94. All cells were labeled with FITC-
Phalloidin (actin cytoskeleton) and DAPI (nuclei). (e-g) The number of PANC1 cells that 
invaded across the membrane was scored. (e) PANC1 were co-cultured with either rat 
fibroblasts (RF) or CAFs transfected with either a nontargeting siRNA or an siRNA 
targeting Dyn2. (f) PANC1 were co-cultured with parental DKO MEFs or DKO MEFs 
treated with tamoxifen to knock out Dyn1/2. Note that PANC1 tumor cells alone are unable 
to invade to the bottom of the transwell filter. This migration is increased upon the addition 
of control fibroblasts, an effect that is potentiated further upon the reduced expression of 
Dyn2. (g) PANC1 cells were co-cultured with DanG pancreatic tumor cells that were 
transfected with either a non-targeting siRNA or an siRNA targeting Dyn2. In the DanG 
tumor cells, note that reduction of Dyn2, which decreases matrix degradation, also decreases 
PANC1 invasion. In both (f) and (g), treatment with the MMP inhibitor BB-94 reduced 
invasion, showing that it is MMP-dependent. Graphed data represent the mean +/− S.E. of 
13-15 10× fields over at least three independent experiments. Bar, 100μm. **p<0.01
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